Singulair

Singulair is a brand name of montelukast, approved by the FDA in the following formulation(s):

SINGULAIR (montelukast sodium - granule; oral)

• 
  Manufacturer: MERCK
  
  Approval date: July 26, 2002
  
  Strength(s): EQ 4MG BASE/PACKET ^[RLD]

SINGULAIR (montelukast sodium - tablet, chewable; oral)

• 
  Manufacturer: MERCK
  
  Approval date: February 20, 1998
  
  Strength(s): EQ 5MG BASE ^[RLD]


• 
  Manufacturer: MERCK
  
  Approval date: March 3, 2000
  
  Strength(s): EQ 4MG BASE
  

SINGULAIR (montelukast sodium - tablet; oral)

• 
  Manufacturer: MERCK
  
  Approval date: February 20, 1998
  
  Strength(s): EQ 10MG BASE ^[RLD]

Has a generic version of Singulair been approved?

No. There is currently no therapeutically equivalent version of Singulair available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Singulair. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
  Patent 5,565,473
  Issued: October 15, 1996
  Inventor(s): Belley; Michel L. & Leger; Serge & Labelle; Marc & Roy; Patrick & Xiang; Yi B. & Guay; Daniel
  Assignee(s): Merck Frosst Canada, Inc.
  Compounds having the formula I: ##STR1## are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
  
  Patent expiration dates:
  
  
  • February 3, 2012
    
    ✓ 
    Patent use: PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA; RELIEF OF SYMPTOMS OF ALLERGIC RHINITIS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • February 3, 2012
    
    ✓ 
    Patent use: PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • February 3, 2012
    
    ✓ 
    Patent use: ASTHMA
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  
  
  • August 3, 2012
    
    ✓ 
    Patent use: ASTHMA
    ✓ 
    Pediatric exclusivity
  
  
  
  • August 3, 2012
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Granule formation
  Patent 8,007,830
  Issued: August 30, 2011
  Inventor(s): Down; Brian
  Assignee(s): Merck Frosst Canada & Co.
  The present invention relates to oral granules of montelukast sodium.
  
  Patent expiration dates:
  
  
  • October 24, 2022
    
    ✓ 
    Drug product
  
  

See also...

• Singulair Consumer Information (Drugs.com)
• Singulair Consumer Information (Wolters Kluwer)
• Singulair Chewable Tablets Consumer Information (Wolters Kluwer)
• Singulair Granules Consumer Information (Wolters Kluwer)
• Singulair Consumer Information (Cerner Multum)
• Singulair Advanced Consumer Information (Micromedex)
• Singulair AHFS DI Monographs (ASHP)
• Montelukast Consumer Information (Wolters Kluwer)
• Montelukast Chewable Tablets Consumer Information (Wolters Kluwer)
• Montelukast Granules Consumer Information (Wolters Kluwer)
• Montelukast Consumer Information (Cerner Multum)
• Montelukast Advanced Consumer Information (Micromedex)
• Montelukast Sodium AHFS DI Monographs (ASHP)

Tramadol Actavis

Tramadol Actavis may be available in the countries listed below.

Ingredient matches for Tramadol Actavis

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramadol Actavis in the following countries:

• Denmark


• Sweden

International Drug Name Search

Levobupivacaina

Levobupivacaina may be available in the countries listed below.

Ingredient matches for Levobupivacaina

Levobupivacaine

Levobupivacaine is reported as an ingredient of Levobupivacaina in the following countries:

• Peru

International Drug Name Search

Taurolite

Taurolite may be available in the countries listed below.

Ingredient matches for Taurolite

Tauroursodeoxycholic Acid

Tauroursodeoxycholic Acid is reported as an ingredient of Taurolite in the following countries:

• China

International Drug Name Search

Azitrom

Azitrom may be available in the countries listed below.

Ingredient matches for Azitrom

Azithromycin

Azithromycin is reported as an ingredient of Azitrom in the following countries:

• Dominican Republic


• Venezuela

International Drug Name Search

Brotizolam

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05CD09

CAS registry number (Chemical Abstracts Service)

0057801-81-7

Chemical Formula

C15-H10-Br-Cl-N4-S

Molecular Weight

393

Therapeutic Categories

Benzodiazepine derivative

Hypnotic and sedative agent

Chemical Name

6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-bromo-4-(2-chlorophenyl)-9-methyl-

Foreign Names

• Brotizolamum (Latin)
• Brotizolam (German)
• Brotizolam (French)
• Brotizolam (Spanish)

Generic Names

• Brotizolam (OS: BAN, DCIT, DCF, JAN, USAN)
• WE 941 (IS: Boehringer Ingelheim)
• WE 941-BS (IS)
• Brotizolam (PH: BP 2010, Ph. Eur. 6)
• Brotizolamum (PH: Ph. Eur. 6)

Brand Names

• Amnezon
  Nisshin Seiyaku - Yamagata, Japan



• Bondormin
  Rafa, Israel



• Brometon
  Mylan Pharmaceutical, Japan



• Brotizolam M
  Sannova, Japan



• Brotizolam-Teva
  Teva, Israel



• Brotizolan
  Nichi-Iko PharmaceuticalJMA, Japan



• Brozom
  Nipro PharmaNipurofama, Japan



• Cinberamin D
  Taiyo Pharmaceutical, Japan



• Cinberamin
  Taiyo Pharmaceutical, Japan



• Dormex
  Recalcine, Chile



• Eurimolan
  Choseido Pharmaceutical, Japan



• Godmin
  Tanabe Mitsubishi, Japan



• Ledolper
  Ohara Yakuhin, Japan



• Lendem
  Medisa Shinyaku, Japan



• Lendorm
  Boehringer Ingelheim, Austria



• Lendormin
  Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Hungary; Boehringer Ingelheim, Japan; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim, Netherlands; Boehringer Ingelheim, Portugal; Boehringer Ingelheim, Serbia; Boehringer Ingelheim, Taiwan; Boehringer Ingelheim, Venezuela; Boehringer Ingelheim, South Africa; Istituto De Angeli, Italy



• Lendormin D
  Boehringer Ingelheim, Japan



• Lindormin
  Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Mexico



• Mederantil (veterinary use)
  Boehringer Ingelheim Animal, Netherlands; Boehringer Ingelheim Animals, New Zealand; Boehringer Ingelheim vet, Switzerland; Boehringer Ingelheim Vetmedica, Ireland; Boehrvet, Germany; Vetlima, Portugal



• Médérantil (veterinary use)
  Boehringer Ingelheim Santé Animale, France



• Nestrom
  Tatsumi Kagaku, Japan



• Noctilan
  Boehringer Ingelheim, Chile



• Noxtal
  Alfresa Pharma Corporation, Japan



• Ronfleman
  Kyowa Yakuhin, Japan



• Sintonal
  Europharma, Spain



• Sorentmin
  Taisho Yakuhin, Japan



• Zestromin
  Towa Yakuhin, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Merlit

Merlit may be available in the countries listed below.

Ingredient matches for Merlit

Levocarnitine

Levocarnitine is reported as an ingredient of Merlit in the following countries:

• Greece

Lorazepam

Lorazepam is reported as an ingredient of Merlit in the following countries:

• Austria

International Drug Name Search